[Antithrombin III level in patients with acute viral myocarditis].
The article focuses on the status of a natural anticoagulant antithrombin III in patients with acute viral myocarditis (AVM) and on modes of treatment thereof. It has been proved that there is a statistically significant correlation between a drop in concentration of antithrombin III and degree of severity of AVM. Convincing, statistically significant data have been obtained that antithrombin III gets increased in AVM patients undergoing complex therapy: in those patients running a mild course of the illness, a mild one presenting with elevated indices for homeostasis, a medium gravity course (diclofenac, heparin, thiotriasoline, quick-frozen plasma), and grave course as well (prednizolon, heparin, thiotriasoline, quick-frozen plasma), which fact can be taken account of in choosing a therapeutic regimen.
Doroshenko
B H
BH
D000208:Acute Disease; D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use*; D000990:Antithrombin III / Q000378:metabolism*; D001777:Blood Coagulation / Q000187:drug effects; D004008:Diclofenac / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D009205:Myocarditis / Q000097:blood* / Q000188:drug therapy / Q000821:virology; D011239:Prednisolone / Q000627:therapeutic use; D012720:Severity of Illness Index; D014230:Triazoles / Q000627:therapeutic use; D014777:Virus Diseases / Q000097:blood* / Q000188:drug therapy
D000925:Anticoagulants; D014230:Triazoles; D004008:Diclofenac; D000990:Antithrombin III; D006493:Heparin; D011239:Prednisolone